Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
BMC Cancer|July 15, 2026
Autologous stem cell transplantation for secondary central nervous system lymphoma: a multicentre retrospective analysisMeredith W Tan, Victor Ling, Jing Yuan Tan, et al.
Antimicrobial Agents and Chemotherapy|February 5, 2020
Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell TransplantationJohan Maertens, Aaron C Logan, Junho Jang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2007
Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGyLiang-Piu Koh, Chien-Shing Chen, Bee-Choo Tai, et al.
Blood|June 22, 2021
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E Horwitz, Patrick J Stiff, Corey Cutler, et al.
Bone Marrow Transplantation|October 6, 2025
Upfront memory T cell add-back with haploidentical TCRαβ-depleted graft in adults with haematological malignancies: a nationwide, multicentre, single-arm, prospective studyLiang-Piu Koh, Yeh Ching Linn, Yang Liang Boo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2020
Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive CancersSoo-Chin Lee, Noriko Shimasaki, Joline S J Lim, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2021
Dendritic cell therapy with CD137L-DC-EBV-VAX in locally recurrent or metastatic nasopharyngeal carcinoma is safe and confers clinical benefitEmily Nickles, Bhushan Dharmadhikari, Li Yating, et al.
Blood|February 16, 2023
Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesisMingrui Guo, Tim Hon Man Chan, Qiling Zhou, et al.
Transplantation and Cellular Therapy|February 12, 2023
Multicenter Long-Term Follow-Up of Allogeneic Hematopoietic Cell Transplantation with Omidubicel: A Pooled Analysis of Five Prospective Clinical TrialsChenyu Lin, Aurelie Schwarzbach, Jaime Sanz, et al.
Science Translational Medicine|October 19, 2022
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphomaJasmine Goh, Sanjay De Mel, Michal M Hoppe, et al.
Pageof 7